Development and validation of a reverse phase HPLC method for the estimation of lacidipine in rat plasma: Application to preclinical pharmacokinetics

Rupesh K. Shirodkar, Lalit Kumar, Chandrasekhar Misra, Renuka Managuli, Zenab Attari, Srinivas Mutalik, Shaila A. Lewis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A simple and reliable reverse phase high performance liquid chromatographic (RP-HPLC) method was developed for quantification of lacidipine in rat plasma using felodipine as internal standard. The protein precipitation technique was adopted for the sample preparation. Separation was carried out on a Hyperclone BDS C18 column (250 × 4.6 mm, 5 μm). The mobile phase was comprised of acetonitrile and 25 mM ammonium acetate buffer (pH 4.5), (60:40 v/v), at the flow rate of 1.0 mL/min. The effluent was monitored using a UV detector at 240 nm. The retention time of lacidipine was found to be 19.97 min. The method was linear over the concentration range of 40-1800 ng/mL. The % RSD values of intra-day and inter-day precision were found to be less than 15 %. Recovery with respect to the area ratio was calculated at LQC, MQC and HQC levels. Stability studies showed that the lacidipine in plasma samples was stable. The method was successfully applied to preclinical pharmacokinetic study of lacidipine after oral administration of lacidipine loaded nanostructured lipid carriers in male Wistar rats.

Original languageEnglish
Pages (from-to)124-129
Number of pages6
JournalLatin American Journal of Pharmacy
Volume35
Issue number1
Publication statusPublished - 2016

Fingerprint

Pharmacokinetics
High Pressure Liquid Chromatography
Felodipine
Oral Administration
Wistar Rats
Buffers
lacidipine
Lipids
Proteins

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Cite this

@article{793508a9ba3a4e56924add30d3c9cdcd,
title = "Development and validation of a reverse phase HPLC method for the estimation of lacidipine in rat plasma: Application to preclinical pharmacokinetics",
abstract = "A simple and reliable reverse phase high performance liquid chromatographic (RP-HPLC) method was developed for quantification of lacidipine in rat plasma using felodipine as internal standard. The protein precipitation technique was adopted for the sample preparation. Separation was carried out on a Hyperclone BDS C18 column (250 × 4.6 mm, 5 μm). The mobile phase was comprised of acetonitrile and 25 mM ammonium acetate buffer (pH 4.5), (60:40 v/v), at the flow rate of 1.0 mL/min. The effluent was monitored using a UV detector at 240 nm. The retention time of lacidipine was found to be 19.97 min. The method was linear over the concentration range of 40-1800 ng/mL. The {\%} RSD values of intra-day and inter-day precision were found to be less than 15 {\%}. Recovery with respect to the area ratio was calculated at LQC, MQC and HQC levels. Stability studies showed that the lacidipine in plasma samples was stable. The method was successfully applied to preclinical pharmacokinetic study of lacidipine after oral administration of lacidipine loaded nanostructured lipid carriers in male Wistar rats.",
author = "Shirodkar, {Rupesh K.} and Lalit Kumar and Chandrasekhar Misra and Renuka Managuli and Zenab Attari and Srinivas Mutalik and Lewis, {Shaila A.}",
note = "cited By 2",
year = "2016",
language = "English",
volume = "35",
pages = "124--129",
journal = "Latin American Journal of Pharmacy",
issn = "0326-2383",
publisher = "Colegio de Farmaceuticos de la Provincia de Buenos Aires",
number = "1",

}

Development and validation of a reverse phase HPLC method for the estimation of lacidipine in rat plasma: Application to preclinical pharmacokinetics. / Shirodkar, Rupesh K.; Kumar, Lalit; Misra, Chandrasekhar; Managuli, Renuka; Attari, Zenab; Mutalik, Srinivas; Lewis, Shaila A.

In: Latin American Journal of Pharmacy, Vol. 35, No. 1, 2016, p. 124-129.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and validation of a reverse phase HPLC method for the estimation of lacidipine in rat plasma: Application to preclinical pharmacokinetics

AU - Shirodkar, Rupesh K.

AU - Kumar, Lalit

AU - Misra, Chandrasekhar

AU - Managuli, Renuka

AU - Attari, Zenab

AU - Mutalik, Srinivas

AU - Lewis, Shaila A.

N1 - cited By 2

PY - 2016

Y1 - 2016

N2 - A simple and reliable reverse phase high performance liquid chromatographic (RP-HPLC) method was developed for quantification of lacidipine in rat plasma using felodipine as internal standard. The protein precipitation technique was adopted for the sample preparation. Separation was carried out on a Hyperclone BDS C18 column (250 × 4.6 mm, 5 μm). The mobile phase was comprised of acetonitrile and 25 mM ammonium acetate buffer (pH 4.5), (60:40 v/v), at the flow rate of 1.0 mL/min. The effluent was monitored using a UV detector at 240 nm. The retention time of lacidipine was found to be 19.97 min. The method was linear over the concentration range of 40-1800 ng/mL. The % RSD values of intra-day and inter-day precision were found to be less than 15 %. Recovery with respect to the area ratio was calculated at LQC, MQC and HQC levels. Stability studies showed that the lacidipine in plasma samples was stable. The method was successfully applied to preclinical pharmacokinetic study of lacidipine after oral administration of lacidipine loaded nanostructured lipid carriers in male Wistar rats.

AB - A simple and reliable reverse phase high performance liquid chromatographic (RP-HPLC) method was developed for quantification of lacidipine in rat plasma using felodipine as internal standard. The protein precipitation technique was adopted for the sample preparation. Separation was carried out on a Hyperclone BDS C18 column (250 × 4.6 mm, 5 μm). The mobile phase was comprised of acetonitrile and 25 mM ammonium acetate buffer (pH 4.5), (60:40 v/v), at the flow rate of 1.0 mL/min. The effluent was monitored using a UV detector at 240 nm. The retention time of lacidipine was found to be 19.97 min. The method was linear over the concentration range of 40-1800 ng/mL. The % RSD values of intra-day and inter-day precision were found to be less than 15 %. Recovery with respect to the area ratio was calculated at LQC, MQC and HQC levels. Stability studies showed that the lacidipine in plasma samples was stable. The method was successfully applied to preclinical pharmacokinetic study of lacidipine after oral administration of lacidipine loaded nanostructured lipid carriers in male Wistar rats.

UR - http://www.scopus.com/inward/record.url?scp=84949937568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949937568&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84949937568

VL - 35

SP - 124

EP - 129

JO - Latin American Journal of Pharmacy

JF - Latin American Journal of Pharmacy

SN - 0326-2383

IS - 1

ER -